SCHEMBL29583255

SCHEMBL29583255

COC(=O)c1cccc2c(Br)cccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.57
MEN1 O00255 5/20 0.57
AHR P35869 1/20 0.57
PRNP P04156 1/20 0.53
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48
ALDH1A1 P00352 2/20 0.47
CFTR P13569 1/20 0.47
HSD17B10 Q99714 1/20 0.47
SLC6A3 Q01959 1/20 0.46
BRD4 O60885 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA5A P35218 1/20 0.46
CA9 Q16790 1/20 0.46
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
ATM Q13315 1/20 0.46
PSMD14 O00487 1/20 0.45
NR4A2 P43354 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2646933 1.00 KMT2A (0.57) KMT2AMEN1AHRPRNPLMNA
SCHEMBL869550 0.89 BRD4 (0.50) KMT2AMEN1AHRLMNATSHR
SCHEMBL70429 0.88 LMNA (0.59) KMT2AMEN1LMNATSHRALDH1A1
SCHEMBL25523280 0.86 SLC6A3 (0.56) KMT2AMEN1AHRPRNPLMNA
SCHEMBL30848483 0.85 PRNP (0.56) KMT2AMEN1AHRPRNPALDH1A1
SCHEMBL4959202 0.85 PRNP (0.56) KMT2AMEN1AHRPRNPALDH1A1
SCHEMBL31525357 0.82 KMT2A (0.45) KMT2AMEN1AHRPRNPLMNA
SCHEMBL29279663 0.81 TSHR (0.52) KMT2AMEN1LMNATSHRALDH1A1
SCHEMBL3230050 0.81 NR4A2 (0.53) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL28485658 0.81 KMT2A (0.61) KMT2AMEN1AHRPRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228625-A1 TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081928-A1 TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed